Skip to main content
Icade logo

Icade — Investor Relations & Filings

Ticker · ICAD ISIN · FR0000035081 LEI · 969500UDH342QLTE1M42 PA Real estate activities
Filings indexed 1,089 across all filing types
Latest filing 2021-05-25 Declaration of Voting R…
Country FR France
Listing PA ICAD

Icade is an integrated real estate company that operates as both a property investor and a property developer. The company's investment division focuses on a portfolio of commercial properties, including offices and business parks, as well as healthcare facilities. As a developer, Icade designs, builds, and manages a diverse range of assets, from residential properties to large-scale urban projects. A central element of its strategy is the creation of innovative and sustainable real estate solutions, with an emphasis on developing low-carbon buildings and functional urban spaces for future communities.

Recent filings

Filing Released Lang Actions
PR ICADE - RESULTS OF SCRIP DIVIDEND ELECTION FOR A PORTION OF THE 2020 FINAL DIVIDEND
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly details the results of a Scrip Dividend Election for the 2020 final dividend, including the percentage of rights exercised in favor of receiving shares, the share price set, the number of new shares created, and the resulting total share capital. This announcement concerns the mechanics and outcome of a dividend payment where shares are issued instead of cash for a portion of the payment. This falls directly under the definition of a 'Notice of Dividend Amount' (DIV) as it relates to the dividend payment, or potentially 'Share Issue/Capital Change' (SHA) due to the creation of new shares. However, since the primary focus is the election result related to the dividend payment, DIV is the most specific fit among the provided options, as it details the outcome of the dividend distribution mechanism. It is not a general earnings release (ER) or a comprehensive quarterly report (IR). Given the specific nature of announcing dividend payment results, DIV is the best classification.
2021-05-25 English
CP ICADE - RÉSULTAT DE L’OPTION DE PAIEMENT D’UNE FRACTION DU SOLDE DU DIVIDENDE 2020 EN ACTIONS
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement detailing the results of a shareholder option regarding the payment of a fraction of the 2020 dividend in new shares. Key elements include the dividend amount, the option period (April 30, 2021, to May 20, 2021), the issuance price of new shares, the resulting creation of new ordinary shares, and the final cash payment date. This announcement directly concerns the distribution of profits and changes to the capital structure via share issuance related to dividends. This fits best under 'Notice of Dividend Amount' (DIV) as it is the primary subject, or potentially 'Share Issue/Capital Change' (SHA). Since the core focus is the outcome of the dividend payment option, DIV is the most specific fit, although it also involves a share issue. Given the context of dividend payment mechanics, DIV is selected. The document is a release/announcement, not a full report.
2021-05-25 French
MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Regulatory Filings Classification · 1% confidence The document is a press release dated May 10th, 2021, providing a monthly update on the 'TOTAL NUMBER OF VOTING RIGHTS AND SHARES' as required by French financial regulations (Article 223-16 of the General Regulation of the AMF and Article L. 233-8-II of the Commercial Code). This specific disclosure relates to the capital structure and voting power, which is a mandatory regulatory filing requirement, but it does not fit neatly into the defined categories like 10-K, ER, or DIV. It is a specific, recurring regulatory disclosure. Among the provided codes, 'RNS' (Regulatory Filings - General regulatory announcements and fallback category) is the most appropriate fit for mandatory, recurring, but non-standardized regulatory updates that don't match the other specific types (like DIRS or MRQ, which focus on trades or major holdings changes, not the total count). Given the nature of the required disclosure, RNS serves as the best general regulatory filing bucket.
2021-05-10 English
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL CONFORMEMENT AUX DISPOSITIONS DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AMF ET L.233-8-II DU CODE
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated May 10, 2021, titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE..." (Monthly information relating to the total number of shares and voting rights...). It explicitly provides a table detailing the total number of shares and voting rights as of April 30, 2021, in compliance with French regulations (AMF and Code de Commerce). This type of regular update on the total share count and voting rights is a specific regulatory disclosure. Among the provided codes, none perfectly match a 'Monthly Share Capital Update'. However, this information relates directly to the company's capital structure and share count, which is often disclosed alongside financing or capital changes. Given the options, this is a specific regulatory disclosure concerning the share base. It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS) if a more specific category exists. Since it details the number of shares and voting rights, it is most closely related to capital structure changes or notifications. The closest fit among the provided options that deals with share counts/capital is 'Share Issue/Capital Change' (SHA), although this is typically for *changes* rather than a monthly static report. Alternatively, it could be classified as a general 'Regulatory Filing' (RNS) due to its mandatory nature under French law. Given the content is a mandatory monthly disclosure about the total number of shares and voting rights, which is a fundamental aspect of the capital structure, SHA is a plausible fit, but RNS is the safest fallback for mandatory, non-standard reports. Since the document explicitly details the capital structure (number of shares), and SHA covers 'Share Issue/Capital Change', I will lean towards SHA as it pertains directly to the share base, even if it's a reporting requirement rather than an active change announcement. However, upon reviewing the definitions, SHA is for *announcements* of new issues/splits. This is a *reporting* of the current state. Therefore, RNS (General regulatory announcements/fallback) is the most appropriate classification for a mandatory monthly disclosure that doesn't fit the other specific financial report types.
2021-05-10 French
ICADE FURTHER EXPANDS ITS HEALTHCARE PORTFOLIO IN ITALY BY ACQUIRING ANOTHER 5 ASSETS FOR €51M
M&A Activity Classification · 1% confidence The document announces a specific corporate transaction: the acquisition of five healthcare assets in Italy for €51M. This involves fundraising, financing, or changes to the company's asset structure/portfolio. It is not a standard periodic report (10-K, IR, ER), nor is it a management discussion (MDA) or an investor presentation (IP). It is a specific announcement regarding capital structure/financing activities related to property investment. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is relatively short (3200 chars), but it contains the full details of the transaction rather than just announcing that a report is available, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule.
2021-05-06 English
LA FONCIE`RE SANTE´ POURSUIT SA CROISSANCE EN ITALIE AVEC 5 NOUVEAUX ACTIFS POUR 51 M€
M&A Activity Classification · 1% confidence The document is a press release announcing a specific corporate transaction: the acquisition of five healthcare assets in Italy for €51M by Icade Healthcare Europe from KOS. This type of announcement, detailing a significant investment, financing activity, or M&A-related transaction (even if it's an acquisition of assets rather than a full company takeover), fits best under Capital/Financing Update (CAP) or M&A Activity (TAR). Since the core focus is on a major investment/acquisition strategy update rather than a tender offer (TAR), and it involves capital deployment for asset growth, CAP is a strong candidate. However, given the context of acquiring operational assets from another entity (KOS) via a sale-and-lease-back, it strongly signals M&A/Transaction activity. Since 'TAR' is defined as 'Merger proposals or takeover bids', and this is an asset acquisition, 'CAP' (Capital/Financing Update) is slightly more appropriate as it reflects a major capital deployment decision supporting growth. Alternatively, if this were a general regulatory filing, RNS would apply, but CAP is more specific to the content. Given the nature of the announcement (major asset acquisition/investment), I will classify it as a Capital/Financing Update (CAP). The document is short and appears to be a standalone announcement, not a full regulatory report.
2021-05-06 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.